Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicenna Therapeutics Corp
T.MDNA
Alternate Symbol(s):
MDNAF
Healthcare
Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company is focused on the development of selective versions of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL-2 with superior...
CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program is designed to enhance the ability of Superkines to treat immunologically cold tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDNA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(10)
•••
Thekid07
X
View Profile
View Bullboard History
Post by
Thekid07
on Sep 15, 2020 8:14pm
Respect
Thank you Pandora Sir!
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Sep 15, 2020 2:26am
RE:started buying
MDNA55 MDNA55 Our Lead Program– A Meaningful Medicine Supporting a Broad Pipeline Our lead candidate MDNA55 is a first-in-class, Interleukin-4 Empowered Cytokine™ that specifically targets the
...more
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
posted May 07, 2024 9:00am by
Cloud DX Inc.
-
|
The company is pleased to announce the execution on April 23, 2024 of a Remote Patient Monitoring Agreement for Cloud DX RPM Services with a Canadian Provincial Health Authority. This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. The contract has a term of 36 months with 2 extensions of 12 months each. The average contract value of each individual subscription is expected to be approximately ...read more
(10)
•••
Thekid07
X
View Profile
View Bullboard History
Post by
Thekid07
on Sep 15, 2020 1:19am
started buying
i owned immu and sold after buyout. Im new to this company and am wondering what phases they are on and the response rates of there drugs or the trial results. Im no doctor just an investor. Pardon my
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Sep 09, 2020 8:11am
Huge meeting with FDA on Sept 29th.
This may be the blast-off news that we are waiting for. Could pave the way to the clinic for MDNA.
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 24, 2020 10:24am
RE:Medicenna Uplisting to NASDAQ
I was hoping for a little brighter introduction to Nasdaq but not to be - at least, so far. Anyway, we're here for whatever it offers.
(19)
•••
PeteZerria
X
View Profile
View Bullboard History
Post by
PeteZerria
on Aug 20, 2020 8:04pm
Medicenna Uplisting to NASDAQ
Medicenna to Commence Trading on Nasdaq TORONTO and HOUSTON, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (Nasdaq: MDNA) (TSX
...more
(8)
•••
Whatsastockdad
X
View Profile
View Bullboard History
Post by
Whatsastockdad
on Aug 11, 2020 2:45pm
Loaded up
This is at discount boys!
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Aug 07, 2020 5:50pm
RE:RE:RE:Nasdaq uplisting update
Thank you Pandora .Been in this one for a while. Guess I,ll hold for a while longer.Has potential to be a ten bagger in my opinion.
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 07, 2020 12:52pm
RE:RE:Nasdaq uplisting update
This is the wording from the news release of about 3 days ago. I do not see anything specific to one quarter or the other therefore no cause for debate: Upcoming Milestones Medicenna will focus
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Jul 21, 2020 9:04pm
RE:Nasdaq uplisting update
The Company stated that they would be upgrading to the Nas in the forth quarter. Where did you get your revised info?
(0)
•••
biotechguy
X
View Profile
View Bullboard History
Post by
biotechguy
on Jul 21, 2020 3:03pm
Nasdaq uplisting update
Upgrading to the Nasdaq will be done in the third quarter, not the fourth, which means an announcement is imminent. Valuation should be significantly higher once this occurs. Should be worth 3-4
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Jul 06, 2020 7:56pm
RE:RE:There now, short covering is completed for this cycle.
Boyz will be Boyz !
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jul 06, 2020 1:32pm
RE:There now, short covering is completed for this cycle.
And now someone smacks it right back down again??
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Jul 04, 2020 8:41am
There now, short covering is completed for this cycle.
Now back to business as the sheep have been whipsawed and the boyz are back in the saddle for more upside action.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share